Valuation: CODON

Market Cap 7L 8L 6L 6L 10.54L 7.23Cr 10.71L 72.66L 28.48L 3.54Cr 28.16L 27.55L 12Cr P/E 2021
-4.36x
P/E 2022 -0.3x
Enterprise Value 15.84L 18.08L 14.65L 13.47L 25.41L 17Cr 25.82L 1.75Cr 68.65L 8.53Cr 67.88L 66.4L 29Cr EV / Sales 2021
3.94x
EV / Sales 2022 1.09x
Free-Float
35.8%
Yield 2021 *
-
Yield 2022 -
Manager TitleAgeSince
Chief Executive Officer 62 16/01/2020
Investor Relations Contact - -
Director TitleAgeSince
Chairman - 29/04/2022
Director/Board Member - 07/07/2010
Director/Board Member 82 12/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%+1.37%+23.89%-7.04% 6.88TCr
-0.54%+1.02%+36.12%+189.96% 5.21TCr
-3.65%+34.50%+34.50%+34.50% 4.35TCr
-0.35%+0.77%-52.11%-53.91% 4.12TCr
-2.93%-4.34%+59.97%-27.21% 3.04TCr
-3.77%-11.22%+90.31%-52.32% 2.45TCr
-1.36%+1.24%+70.42%+80.67% 2.34TCr
+3.99%+3.12%+3.87%+200.81% 1.98TCr
+0.26%-1.74%+70.47%+125.19% 1.66TCr
Average -0.99%-1.02%+37.49%+54.52% 3.56TCr
Weighted average by Cap. -1.17%-0.46%+30.62%+45.30%

Financials

2021 2022
Net sales 98.03L 1.12Cr 90.61L 83.34L 1.57Cr 107.85Cr 1.6Cr 11Cr 4.25Cr 53Cr 4.2Cr 4.11Cr 181.81Cr 62.41L 71.21L 57.69L 53.06L 1Cr 69Cr 1.02Cr 6.9Cr 2.7Cr 34Cr 2.67Cr 2.62Cr 115.75Cr
Net income -93.22L -1.06Cr -86.17L -79.25L -1.5Cr -102.56Cr -1.52Cr -10Cr -4.04Cr -50Cr -3.99Cr -3.91Cr -172.89Cr -1.7Cr -1.94Cr -1.57Cr -1.44Cr -2.72Cr -186.81Cr -2.77Cr -19Cr -7.36Cr -91Cr -7.27Cr -7.12Cr -314.92Cr
Net Debt -3L -3L -3L -2L -5L -3.22Cr -5L -32.38L -12.69L -1.58Cr -12.55L -12.28L -5.43Cr 9L 10.58L 9L 8L 14.87L 10Cr 15.11L 1.02Cr 40.16L 4.99Cr 39.71L 38.85L 17Cr
Logo CODON
CoDon AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. It also offers biopsy, cultivation, transplantation, rehabilitation and others.
Employees
-